BRPI0518963A2 - 5-amino-4-hidràxi-2-isopropil-7-[4-metàxi-3-(3-metoxipr opàxi)benzil]-8-metil-nonanamidas - Google Patents

5-amino-4-hidràxi-2-isopropil-7-[4-metàxi-3-(3-metoxipr opàxi)benzil]-8-metil-nonanamidas

Info

Publication number
BRPI0518963A2
BRPI0518963A2 BRPI0518963-2A BRPI0518963A BRPI0518963A2 BR PI0518963 A2 BRPI0518963 A2 BR PI0518963A2 BR PI0518963 A BRPI0518963 A BR PI0518963A BR PI0518963 A2 BRPI0518963 A2 BR PI0518963A2
Authority
BR
Brazil
Prior art keywords
amino
alkylamino
mono
nonanamides
alkyl
Prior art date
Application number
BRPI0518963-2A
Other languages
English (en)
Inventor
Peter Herold
Stefan Stutz
Robert Mah
Vincenzo Tschinke
Original Assignee
Speedel Experimenta Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Speedel Experimenta Ag filed Critical Speedel Experimenta Ag
Publication of BRPI0518963A2 publication Critical patent/BRPI0518963A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)

Abstract

5-AMINO-4-HIDRàXI-2-ISOPROPIL-7-[4-METàXI-3- (3-METOXIPROPàXI)BENZIL]-8-METIL- NONANAMIDAS. A presente invenção refere-se a compostos da Fórmula geral (I) em que R é heterociclila que é ligado por meio de um átomo de carbono e é mono ou polissubstituído por C~ 1-6-~alquila, trifluorometila, nitro, amino, C~ 1-6-~ alquilamino, di- C~ 1-6-~ alquilamino, C~ 2-6-~ alquenila, C~ 2-6-~ alquinila, C~ 1-6-~ alcóxi, C~ 1-6-~ alquilcarbonilóxi, C~ 0-6~-aIquiIcar-bonilamino, C~ 1-6-~alcoxicarbonilamino, hidroxila, halogênio, óxido, ciano, N-mono- ou N,N-di- C~ 1-8-~ carbamoíla opcionalmente alquilado, C~ 1-6-~ alquilenodi-óxi ou carboxila opcionalmente esterificado, ou é substituído por oxo e mono- ou polissubstituido por C~ 1-6-~ alquila, trifluo-rometila, nitro, amino, C~ 1-6-~alqui-lamino, di- C~ 1-6-~alquilamino, C~ 2-6-~alquenila, C~ 2-6-~ aIquinila, C~ 1-6-~alcóxi, C~ 1-6-~alquilcarbonilóxi, C~ 0-6-~alquilcarbonilamino, C~ 1-6-~ alcoxicarbonilamino, hidroxila, halogênio, óxido, ciano, opcionalmente N- mono- ou N,N-di- C~ 1-8-~ carbamoila alquilado, C~ 1-6-~alquilenodióxi ou carboxila opcionalmente esterificado, e sais, especialmente sais farmaceuticamente usáveis têm propriedades de inibição de renina e podem ser empregados como medicamentos.
BRPI0518963-2A 2004-12-10 2005-12-09 5-amino-4-hidràxi-2-isopropil-7-[4-metàxi-3-(3-metoxipr opàxi)benzil]-8-metil-nonanamidas BRPI0518963A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH20492004 2004-12-10
PCT/EP2005/056623 WO2006061427A1 (en) 2004-12-10 2005-12-09 5-amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropxy)benzyl]-8-methylnonanamides

Publications (1)

Publication Number Publication Date
BRPI0518963A2 true BRPI0518963A2 (pt) 2008-12-16

Family

ID=35668936

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518963-2A BRPI0518963A2 (pt) 2004-12-10 2005-12-09 5-amino-4-hidràxi-2-isopropil-7-[4-metàxi-3-(3-metoxipr opàxi)benzil]-8-metil-nonanamidas

Country Status (10)

Country Link
US (1) US20080167381A1 (pt)
EP (1) EP1819675A1 (pt)
JP (1) JP2008523036A (pt)
CN (1) CN101076518A (pt)
AR (1) AR052150A1 (pt)
BR (1) BRPI0518963A2 (pt)
CA (1) CA2590252A1 (pt)
IL (1) IL183771A0 (pt)
TW (1) TW200633983A (pt)
WO (1) WO2006061427A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005095876A1 (en) 2004-04-01 2005-10-13 Cucumber Limited Delivery and storage of goods
PL1937248T3 (pl) * 2005-09-17 2010-11-30 Novartis Ag Amidy kwasów alkanowych podstawione nasyconymi grupami O-heterocyklicznymi
EP1867329A3 (en) * 2006-06-14 2008-05-07 Speedel Experimenta AG 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamides as therapeutic compounds
EP1958666A1 (en) * 2007-02-13 2008-08-20 Speedel Experimenta AG Heterocyclic-substituted alkanamides as therapeutic compounds
EP2075244A1 (en) 2007-12-24 2009-07-01 DSMIP Assets B.V. New route to building block for making renin inhibitors
EP2225200B1 (en) * 2007-12-24 2013-10-16 DSM IP Assets B.V. Convergent synthesis of renin inhibitors and intermediates useful therein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
EP1712548A3 (en) * 2004-03-19 2006-11-02 Speedel Experimenta AG 5-amino-4-hydroxy-7-(pyridinylmethyl)-alkanamide derivatives and related compounds as renin inhibitors for the treatment of hypertension

Also Published As

Publication number Publication date
US20080167381A1 (en) 2008-07-10
JP2008523036A (ja) 2008-07-03
WO2006061427A1 (en) 2006-06-15
IL183771A0 (en) 2007-09-20
TW200633983A (en) 2006-10-01
CN101076518A (zh) 2007-11-21
EP1819675A1 (en) 2007-08-22
AR052150A1 (es) 2007-03-07
CA2590252A1 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
GEP20115306B (pt)
BRPI0913457A2 (pt) "composto, composição farmacêutica, e, uso do composto"
ECSP099755A (es) Derivados de pirrolopiridina y su uso como inhibidores de bace
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
UA109525C2 (xx) Алкіламідна сполука і її застосування
BRPI0818193B8 (pt) composto, composição farmacêutica, e, uso de um composto
ATE542813T1 (de) 6-substituierte 2- heterocyclylaminopyrazinverbindungen als chk-1- inhibitoren
UA102251C2 (ru) Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера
TW200833675A (en) Nicotinamide derivatives
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
CY1111170T1 (el) Ενωσεις διαρυλ αιθερα ουριας
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
UY31083A1 (es) Derivados de sulfoximinas para la inhibicion de b-secretasa
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
UY29927A1 (es) Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones
BRPI0617165A2 (pt) Compostos inibidores mek, composições farmacêuticas que os contem e métodos de uso dos mesmos
BRPI0518963A2 (pt) 5-amino-4-hidràxi-2-isopropil-7-[4-metàxi-3-(3-metoxipr opàxi)benzil]-8-metil-nonanamidas
UY31906A (es) Derivados de n-cicloalquil-3-fenilnicotinamida que inhiben pgds, sus composiciones, su uso para el tratamiento por ejemplo de afecciones alérgicas y respiratorias.
ATE404536T1 (de) Substituierte chinolinderivate als inhibitoren von mitotischem kinesin
EA201000750A1 (ru) Производные 4-бензиламино-1-карбоксиацилпиперидина, как ингибиторы бпхэ (белка-переносчика холестериловогоэфира), применимые для лечения заболеваний, таких как гиперлипидемия или артериосклероз
MA30821B1 (fr) Derives de pyrazoline utiles comme antagonistes des recepteurs de mineralocorticoïdes
MX2009008779A (es) Composicion farmacéutica que comprende derivado de pirazina y método para usar el derivado de pirazina en combinación.
EA201000884A1 (ru) Производные 1,2-дизамещенного 4-бензиламинопирролидина в качестве ингибиторов белка-переносчика холестерилового эфира, используемые для лечения заболеваний, таких как гиперлипидемия или артериосклероз
MY150075A (en) Novel phosphodiesterase inhibitors
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]